Andersson GB. Epidemiological features of chronic low-back pain. lancet. 1999;354:581–5.
Article CAS PubMed Google Scholar
Graven-Nielsen T, Arendt-Nielsen L. Assessment of mechanisms in localized and widespread musculoskeletal pain. Nat Rev Rheumatol. 2010;6:599–606.
Corbett DB, Simon CB, Manini TM, George SZ, Riley JL III, Fillingim RB. Movement-evoked pain: transforming the way we understand and measure pain. Pain. 2019;160:757.
Article PubMed PubMed Central Google Scholar
Esteve R, Ramírez-Maestre C, López-Martínez AE. Adjustment to chronic pain: the role of pain acceptance, coping strategies, and pain-related cognitions. Ann Behav Med. 2007;33:179–88.
Cherkin DC, Sherman KJ, Balderson BH, Cook AJ, Anderson ML, Hawkes RJ, et al. Effect of mindfulness-based stress reduction vs cognitive behavioral therapy or usual care on back pain and functional limitations in adults with chronic low back pain: a randomized clinical trial. JAMA. 2016;315:1240–9.
Article CAS PubMed PubMed Central Google Scholar
Wells RE, O’Connell N, Pierce CR, Estave P, Penzien DB, Loder E, et al. Effectiveness of mindfulness meditation vs headache education for adults with migraine: a randomized clinical trial. JAMA Intern Med. 2021;181:317–28.
Colloca L, Petrovic P, Wager TD, Ingvar M, Benedetti F. How the number of learning trials affects placebo and nocebo responses. Pain®. 2010;151:430–39.
De Pascalis V, Chiaradia C, Carotenuto E. The contribution of suggestibility and expectation to placebo analgesia phenomenon in an experimental setting. Pain. 2002;96:393–402.
Kaptchuk TJ. The placebo effect in alternative medicine: can the performance of a healing ritual have clinical significance? Ann Intern Med. 2002;136:817–25.
Wager TD, Atlas LY, Leotti LA, Rilling JK. Predicting individual differences in placebo analgesia: contributions of brain activity during anticipation and pain experience. J Neurosci. 2011;31:439–52.
Article CAS PubMed PubMed Central Google Scholar
Zeidan F, Johnson SK, Gordon NS, Goolkasian P. Effects of brief and sham mindfulness meditation on mood and cardiovascular variables. J Alter Complement Med. 2010;16:867–73.
Zeidan F, Emerson NM, Farris SR, Ray JN, Jung Y, McHaffie JG, et al. Mindfulness meditation-based pain relief employs different neural mechanisms than placebo and sham mindfulness meditation-induced analgesia. J Neurosci. 2015;35:15307–25.
Article CAS PubMed PubMed Central Google Scholar
Wells RE, Collier J, Posey G, Morgan A, Auman T, Strittmatter B, et al. Attention to breath sensations does not engage endogenous opioids to reduce pain. Pain. 2020;161:1884–93.
Article PubMed PubMed Central Google Scholar
Adler-Neal AL, Waugh CE, Garland EL, Shaltout HA, Diz DI, Zeidan F. The role of heart rate variability in mindfulness-based pain relief. J pain. 2020;21:306–23.
Zubieta J-K, Smith YR, Bueller JA, Xu Y, Kilbourn MR, Jewett DM, et al. Regional mu opioid receptor regulation of sensory and affective dimensions of pain. Science. 2001;293:311–15.
Article CAS PubMed Google Scholar
Mayer DJ, Price DD, Rafii A. Antagonism of acupuncture analgesia in man by the narcotic antagonist naloxone. Brain Res. 1977;121:368–72.
Article CAS PubMed Google Scholar
Watkins LR, Mayer DJ. Organization of endogenous opiate and nonopiate pain control systems. Science. 1982;216:1185–92.
Article CAS PubMed Google Scholar
Eippert F, Bingel U, Schoell ED, Yacubian J, Klinger R, Lorenz J, et al. Activation of the opioidergic descending pain control system underlies placebo analgesia. Neuron. 2009;63:533–43.
Article CAS PubMed Google Scholar
Levine JD, Gordon NC, Fields HL. The mechanism of placebo analgesia. Lancet. 1978;2:654–7.
Article CAS PubMed Google Scholar
Zubieta J-K, Bueller JA, Jackson LR, Scott DJ, Xu Y, Koeppe RA, et al. Placebo effects mediated by endogenous opioid activity on μ-opioid receptors. J Neurosci. 2005;25:7754–62.
Article CAS PubMed PubMed Central Google Scholar
Sprenger C, Eippert F, Finsterbusch J, Bingel U, Rose M, Büchel C. Attention modulates spinal cord responses to pain. Curr Biol. 2012;22:1019–22.
Article CAS PubMed Google Scholar
Taylor JJ, Borckardt JJ, Canterberry M, Li X, Hanlon CA, Brown TR, et al. Naloxone-reversible modulation of pain circuitry by left prefrontal rTMS. Neuropsychopharmacology. 2013;38:1189–97.
Article CAS PubMed PubMed Central Google Scholar
Oliva V, Hartley-Davies R, Moran R, Pickering AE, Brooks JC. Simultaneous brain, brainstem, and spinal cord pharmacological-fMRI reveals involvement of an endogenous opioid network in attentional analgesia. Elife. 2022;11:e71877.
Article CAS PubMed PubMed Central Google Scholar
Zeidan F, Adler-Neal AL, Wells RE, Stagnaro E, May LM, Eisenach JC, et al. Mindfulness-meditation-based pain relief is not mediated by endogenous opioids. J Neurosci. 2016;36:3391–7.
Article CAS PubMed PubMed Central Google Scholar
Martikainen IK, Pecina M, Love TM, Nuechterlein EB, Cummiford CM, Green CR, et al. Alterations in endogenous opioid functional measures in chronic back pain. J Neurosci. 2013;33:14729–37.
Article CAS PubMed PubMed Central Google Scholar
Harris RE, Clauw DJ, Scott DJ, McLean SA, Gracely RH, Zubieta J-K. Decreased central μ-opioid receptor availability in fibromyalgia. J Neurosci. 2007;27:10000–06.
Article CAS PubMed PubMed Central Google Scholar
Bruehl S, Chung OY, Burns JW, Diedrich L. Trait anger expressiveness and pain-induced beta-endorphin release: support for the opioid dysfunction hypothesis. Pain. 2007;130:208–15.
Article CAS PubMed PubMed Central Google Scholar
Thompson SJ, Pitcher MH, Stone LS, Tarum F, Niu G, Chen X, et al. Chronic neuropathic pain reduces opioid receptor availability with associated anhedonia in rat. Pain. 2018;159:1856.
Article CAS PubMed PubMed Central Google Scholar
Schrepf A, Harper DE, Harte SE, Wang H, Ichesco E, Hampson JP, et al. Endogenous opioidergic dysregulation of pain in fibromyalgia: a PET and fMRI study. Pain. 2016;157:2217.
Article CAS PubMed PubMed Central Google Scholar
Willoch F, Schindler F, Wester HJ, Empl M, Straube A, Schwaiger M, et al. Central poststroke pain and reduced opioid receptor binding within pain processing circuitries: a [11C] diprenorphine PET study. Pain. 2004;108:213–20.
Article CAS PubMed Google Scholar
Wasan AD, Loggia ML, Chen LQ, Napadow V, Kong J, Gollub RL. Neural correlates of chronic low back pain measured by arterial spin labeling. J Am Soc Anesthesiologists. 2011;115:364–74.
May LM, Kosek P, Zeidan F, Berkman ET. Enhancement of meditation analgesia by opioid antagonist in experienced meditators. Psychosom Med. 2018;80:807.
Article CAS PubMed PubMed Central Google Scholar
Loggia ML, Kim J, Gollub RL, Vangel MG, Kirsch I, Kong J, et al. Default mode network connectivity encodes clinical pain: an arterial spin labeling study. PAIN®. 2013;154:24–33.
Cleeland CS, Ryan K. Pain assessment: global use of the Brief Pain Inventory. Annals of the Academy of Medicine, Singapore. 1994;23:129–38.
Sullivan MJ, Bishop SR, Pivik J. The pain catastrophizing scale: development and validation. Psychological Assess. 1995;7:524.
Roland M, Morris R. A study of the natural history of low-back pain: part II: development of guidelines for trials of treatment in primary care. Spine. 1983;8:145–50.
Article CAS PubMed Google Scholar
Trøstheim M, Eikemo M, Haaker J, Frost JJ, Leknes S. Opioid antagonism in humans: a primer on optimal dose and timing for central mu-opioid receptor blockade. Neuropsychopharmacology. 2023;48:299–307.
Dworkin RH, Turk DC, Farrar JT, Haythornthwaite JA, Jensen MP, Katz NP, et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain. 2005;113:9–19.
Comments (0)